Vanda Pharmaceuticals
VNDA
VNDA
139 hedge funds and large institutions have $212M invested in Vanda Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 45 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
-7
Holders Change %
-4.79%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
49
Reduced
45
Closed
28
Calls
$197K
Puts
$6.06M
Net Calls
-$5.87M
Net Calls Change
-$3.38M
Top Buyers
| 1 |
Millennium Management
New York
|
$14.7M |
| 2 |
Two Sigma Advisers
New York
|
$3.82M |
| 3 |
Citigroup
New York
|
$4.16M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$2.23M |
| 5 |
Two Sigma Investments
New York
|
$2.49M |
